LHK antigen

The "LHK antigen" is not an established or widely accepted antigen, receptor, or molecular therapeutic target in immunology, oncology, or cell biology. The only available literature reference describes the LHK antigen as a putative novel death receptor possibly restricted to epithelial cells and implicated in apoptotic cell death, but lacks additional details, validation, or subsequent citations[10]. There is no standard abbreviation, molecular classification, or recognized role in disease or therapy. Verification in major scientific taxonomies like UniProt, HGNC, or NCBI is absent, and no common aliases exist. If further information or clarification of the name becomes available, structured curation may be possible—otherwise, this entity should be flagged as likely incorrect or insufficiently defined for therapeutic or biomarker targeting.